CORDIS
EU research results

CORDIS

English EN

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

Project information

Grant agreement ID: 814607

Status

Ongoing project

  • Start date

    1 April 2019

  • End date

    31 March 2023

Funded under:

H2020-EU.2.1.3.

H2020-EU.2.1.2.

  • Overall budget:

    € 18 344 674,10

  • EU contribution

    € 14 534 365,88

Coordinated by:

TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL

Spain

Objective

Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB)
To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL

Address

Area Industrial Perguita C/A 1
31210 Los Arcos

Spain

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 350 398,13

Participants (27)

STATENS ARBEIDSMILJOINSTITUTT

Norway

EU Contribution

€ 615 000

KERALTY SAS

Colombia

EU Contribution

€ 297 500

FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Spain

EU Contribution

€ 633 517,50

INSTITUTUL DE CHIMIE FIZICA ILIE MURGULESCU

Romania

EU Contribution

€ 324 250

FUNDACION TECNALIA RESEARCH & INNOVATION

Spain

EU Contribution

€ 555 643,75

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.

Spain

EU Contribution

€ 968 657,50

VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.

Belgium

EU Contribution

€ 512 500

UNIVERSITA DEGLI STUDI DI PAVIA

Italy

EU Contribution

€ 487 500

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 430 250

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Ireland

EU Contribution

€ 801 885

RESONANT CIRCUITS LIMITED

United Kingdom

EU Contribution

€ 464 194,50

SINTEF AS

Norway

EU Contribution

€ 799 037,50

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Portugal

EU Contribution

€ 714 815

LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA

Portugal

EU Contribution

€ 669 625

GREENDECISION SRL

Italy

EU Contribution

€ 553 875

EUROSCAN INTERNATIONAL NETWORK EV

Germany

EU Contribution

€ 171 250

THE UNIVERSITY OF LIVERPOOL

United Kingdom

EU Contribution

€ 732 500

COUNCIL OF EUROPEAN BIOREGIONS

Belgium

EU Contribution

€ 496 250

DEPARTAMENTO DE SALUD GOBIERNO VASCO

Spain

EU Contribution

€ 306 880

MARACA INTERNATIONAL

Belgium

EU Contribution

€ 413 000

STRYKER TRAUMA GMBH

Germany

STRYKER TRAUMA GMBH

Germany

EU Contribution

€ 556 087

TECHNISCHE UNIVERSITEIT EINDHOVEN

Netherlands

EU Contribution

€ 853 000

BIOKERALTY RESEARCH INSTITUTE AIE

Spain

EU Contribution

€ 1 826 750

HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD

China

CHINA PHARMACEUTICAL UNIVERSITY

China

NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY, CHINA

China

Project information

Grant agreement ID: 814607

Status

Ongoing project

  • Start date

    1 April 2019

  • End date

    31 March 2023

Funded under:

H2020-EU.2.1.3.

H2020-EU.2.1.2.

  • Overall budget:

    € 18 344 674,10

  • EU contribution

    € 14 534 365,88

Coordinated by:

TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL

Spain